- Home
- KOD
as 07-26-2024 4:00pm EST
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | 150.8M | IPO Year: | 2018 |
| Target Price: | $3.33 | AVG Volume (30 days): | 333.8K |
| Analyst Decision: | Sell | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.37 - $7.77 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Kodiak Sciences Inc (KOD)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | KOD | See Remarks | Jun 15 '24 | Sell | $2.75 | 2,874 | $7,903.50 | 182,164 | SEC Form 4 |
| BORGESON JOHN A. | KOD | See Remarks | Jun 11 '24 | Sell | $2.92 | 1,558 | $4,549.36 | 179,544 | SEC Form 4 |
Latest Kodiak Sciences Inc News
KOD Breaking Stock News: Dive into KOD Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
Kodiak Sciences Inc. (NASDAQ:KOD) is definitely on the radar of institutional investors who own 50% of the company
Zacks
16 days ago
All You Need to Know About Kodiak Sciences (KOD) Rating Upgrade to Buy
Zacks
a month ago
Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
Zacks
a month ago
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
2 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
2 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
Compare KOD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KOD Kodiak Sciences Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.